STOCK TITAN
  1. Home
  2. Sec-filings
  3. GSK
  4. [6-K] GSK plc American Current Report (Foreign Issuer)

[6-K] GSK plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock GSK logo
GSK PLC

NYSE:GSK

GSK Rankings

#170 Ranked by Market Cap
#956 Ranked by Dividends

GSK Latest News

Oct 1, 2025
New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
Jul 27, 2025
Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Jul 24, 2025
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
Jul 17, 2025
US FDA Approves GSK’s SHINGRIX in a Prefilled Syringe Presentation
Jul 10, 2025
GSK begins shipping influenza vaccine doses for the 2025-26 flu season

GSK Latest SEC Filings

Sep 22, 2025
[6-K] GSK plc Current Report (Foreign Issuer)
Sep 19, 2025
[6-K] GSK plc Current Report (Foreign Issuer)
Sep 18, 2025
[6-K] GSK plc Current Report (Foreign Issuer)
Sep 17, 2025
[6-K] GSK plc Current Report (Foreign Issuer)
Sep 17, 2025
[6-K] GSK plc Current Report (Foreign Issuer)

GSK Stock Data

87.92B
2.03B
0.06%
19.09%
0.55%
Drug Manufacturers - General
Healthcare
Link
United Kingdom
London